Vfend IV (voriconazole)

Approved for Invasive aspergillosis, Candidemia in non-neutropenic patients, Serious fungal infections caused by Scedosporium and Fusarium species. Inhibits fungal cytochrome P450-dependent 14-alpha-sterol demethylase, blocking the conversion of lanosterol to ergosterol. Ergosterol depletion disrupts fungal cell membrane integrity and function. Side effects, costs, interactions, manufacturer,…

Loading full data from Know Your Drugs Institute…